Wilmer W A, Tan L C, Dickerson J A, Danne M, Rovin B H
Department of Medicine, Ohio State University, Columbus, Ohio 43210, USA.
J Biol Chem. 1997 Apr 18;272(16):10877-81. doi: 10.1074/jbc.272.16.10877.
Interleukin-1beta (IL-1beta) significantly influences renal cellular function through the induction of several gene products. The molecular mechanisms involved in gene regulation by IL-1beta are poorly understood; however, the appearance of novel tyrosine phosphoproteins in IL-1beta-treated cells suggests that IL-1beta may function through tyrosine phosphoprotein intermediates. The mitogen-activated protein (MAP) kinases are tyrosine phosphoproteins that could potentially mediate the effects of IL-1beta. Protein tyrosine phosphorylation following IL-1beta treatment may be dependent on redox changes since the IL-1beta receptor is not a protein-tyrosine kinase and oxidation has been shown to induce tyrosine phosphorylation. In this report we demonstrate that conditioning human glomerular mesangial cells with IL-1beta results in the tyrosine phosphorylation and activation of two members of the MAP kinase family, extracellular signal-regulated protein kinase 2 (ERK2) and p54 Jun-NH2-terminal kinase (JNK). This effect of IL-1beta is abrogated by pretreating cells with the antioxidants N-acetyl-L-cysteine or dithiothreitol. Furthermore, the effects of IL-1beta on ERK and JNK activation are reproduced by treating mesangial cells with membrane-permeable oxidants. IL-1beta and oxidants also cause phosphorylation and activation of the upstream ERK regulatory element MAP kinase kinase. Interestingly, IL-1beta, but not exogenous oxidants, causes phosphorylation of the upstream JNK activator, JNK kinase. These data indicate that IL-1beta activates ERK2 through an oxidation-dependent pathway. Exogenous oxidants and IL-1beta activate JNK through different upstream mechanisms; however, antioxidant inhibition of JNK activation indicates that endogenous oxidants may play a role in IL-1beta-induced JNK activation. Thus IL-1beta may affect mesangial cell function by activating MAP kinases, which can then regulate gene transcription. Furthermore, reactive oxygen species released during inflammatory glomerular injury may also affect mesangial function through a MAP kinase signal.
白细胞介素-1β(IL-1β)通过诱导多种基因产物显著影响肾细胞功能。目前对IL-1β参与基因调控的分子机制了解甚少;然而,在经IL-1β处理的细胞中出现的新型酪氨酸磷酸化蛋白表明,IL-1β可能通过酪氨酸磷酸化蛋白中间体发挥作用。丝裂原活化蛋白(MAP)激酶是酪氨酸磷酸化蛋白,可能介导IL-1β的作用。IL-1β处理后的蛋白酪氨酸磷酸化可能依赖于氧化还原变化,因为IL-1β受体不是蛋白酪氨酸激酶,且氧化已被证明可诱导酪氨酸磷酸化。在本报告中,我们证明用IL-1β预处理人肾小球系膜细胞会导致MAP激酶家族的两个成员,即细胞外信号调节蛋白激酶2(ERK2)和p54 Jun-NH2末端激酶(JNK)发生酪氨酸磷酸化并激活。用抗氧化剂N-乙酰-L-半胱氨酸或二硫苏糖醇预处理细胞可消除IL-1β的这种作用。此外,用膜通透性氧化剂处理系膜细胞可重现IL-1β对ERK和JNK激活的作用。IL-1β和氧化剂还会导致上游ERK调节元件MAP激酶激酶的磷酸化和激活。有趣的是,IL-1β而非外源性氧化剂会导致上游JNK激活剂JNK激酶的磷酸化。这些数据表明,IL-1β通过氧化依赖性途径激活ERK2。外源性氧化剂和IL-1β通过不同的上游机制激活JNK;然而,抗氧化剂对JNK激活的抑制表明内源性氧化剂可能在IL-1β诱导的JNK激活中起作用。因此,IL-1β可能通过激活MAP激酶来影响系膜细胞功能,进而调节基因转录。此外,炎症性肾小球损伤期间释放的活性氧也可能通过MAP激酶信号影响系膜功能。